Snowball logo
logo
ACTU

Actuate Therapeutics, Inc. Common stock

ACTU NASDAQ
$2.76+$0.08  (2.99%)

Frequently asked questions

What sector does Actuate Therapeutics, Inc. Common stock (ACTU) operate in?

Actuate Therapeutics, Inc. Common stock belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Actuate Therapeutics, Inc. Common stock (ACTU) current stock price?

As of the latest data, Actuate Therapeutics, Inc. Common stock stock price is $2.76, with a previous close of $2.68. Actuate Therapeutics, Inc. Common stock gained $0.08 in the last trading session, representing a 2.99% increase.

What is Actuate Therapeutics, Inc. Common stock (ACTU) current market capitalization?

Actuate Therapeutics, Inc. Common stock market cap is approximately 64.15 million.

What is Actuate Therapeutics, Inc. Common stock (ACTU) Earnings Per Share (EPS)?

The trailing EPS is -$3.11, and the forward EPS is -$1.29.

What is Actuate Therapeutics, Inc. Common stock (ACTU) EBITDA?

Actuate Therapeutics, Inc. Common stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -5.40 million.

Does Actuate Therapeutics, Inc. Common stock (ACTU) pay dividends?

No. Actuate Therapeutics, Inc. Common stock does not pay a dividend.

When is Actuate Therapeutics, Inc. Common stock (ACTU) next earnings report?

Actuate Therapeutics, Inc. Common stock is expected to release its next earnings report on December 31, 2025.

What is Actuate Therapeutics, Inc. Common stock (ACTU) beta (volatility) score?

Actuate Therapeutics, Inc. Common stock has a beta of 0.063, indicating lower volatility than the overall market.